Key information

🔎 Fund Overview

Sanara MedTech Inc. is a medical technology company. The Company is focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. It has products across surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products include CellerateRX Surgical Activated Collagen, TEXAGEN, BiFORM, AMPLIFY and ALLOCYTE, FORTIFY TRG Tissue Repair Graft, and FORTIFY FLOWABLE Extracellular Matrix are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. Its chronic wound care products include HYCOL Hydrolyzed Collagen, BIAKOS Antimicrobial Skin and Wound Cleanser and BIAKOS Antimicrobial Wound Gel, are targeted for use across the post-acute continuum of care, including home health, hospice, physician offices, podiatrists, retail, skilled nursing facilities and wound care clinics.